Related Experiment Video
Updated: Jun 12, 2026
09:57
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
Reduction-sensitive, robust vesicles with a non-covalently modifiable surface as a multifunctional drug-delivery
Kyeng Min Park1, Don-Wook Lee, Bijay Sarkar
1National Creative Research Initiative Center for Smart Supramolecules (CSS) Department of Chemistry and Division of Advanced Materials Science Pohang University of Science and Technology (POSTECH) Pohang 790-784, Republic of Korea.
Small (Weinheim an Der Bergstrasse, Germany)
|June 22, 2010
Summary
Researchers developed a novel reduction-sensitive vesicle (SSCB[6]VC) for drug delivery. This biocompatible platform enhances anticancer drug efficacy and offers versatile applications in targeted cancer therapy.
Area of Science:
- Supramolecular Chemistry
- Materials Science
- Nanotechnology
Background:
- Development of advanced drug delivery systems is crucial for improving therapeutic efficacy and reducing side effects.
- Existing systems often face challenges in stability, targeted delivery, and controlled release.
- Cucurbit[6]uril (CB[6]) based supramolecular assemblies offer unique host-guest properties for material design.
Purpose of the Study:
- To design and synthesize a novel reduction-sensitive, robust, and biocompatible vesicle (SSCB[6]VC) for targeted drug delivery.
- To evaluate the potential of SSCB[6]VC as a multifunctional platform for cancer therapy.
- To demonstrate enhanced drug efficacy and cellular uptake using functionalized SSCB[6]VC.
Main Methods:
- Self-assembly of an amphiphilic CB[6] derivative containing disulfide bonds to form SSCB[6]VC.
- Surface modification of SSCB[6]VC using host-guest chemistry with targeting ligands (folate-spermidine) and imaging probes (FITC-spermidine).
- In vitro evaluation of cellular internalization, triggered drug release in a reducing environment, and cytotoxicity of doxorubicin-loaded SSCB[6]VC.
Main Results:
- Successful synthesis of SSCB[6]VC with high structural stability and biocompatibility.
- Facile and modular surface functionalization via host-guest interactions.
- Efficient cellular uptake via receptor-mediated endocytosis and triggered doxorubicin release in cytoplasm.
- Significantly enhanced cytotoxicity of doxorubicin-loaded SSCB[6]VC against cancer cells.
Conclusions:
- SSCB[6]VC represents a versatile, multifunctional platform for targeted drug delivery, leveraging supramolecular chemistry and CB[6] properties.
- The reduction-sensitive nature and facile modification of SSCB[6]VC enable efficient intracellular drug release and targeted therapy.
- This strategy holds promise for advancing cancer therapy and can be extended to other biomedical applications like gene delivery.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:12Clathrin Coated Vesicles
Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...